The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
A serum circulating miRNA diagnostic test to identify asymptomatic high‐risk individuals with early stage lung cancer
Open accessAbstract
Lung cancer is the first cause of cancer mortality worldwide, and its early detection is currently the main available strategy to improve disease prognosis. While early diagnosis can be successfully achieved through tomography-based population screenings in high-risk individuals, simple methodologies are needed for effective cancer prevention programs. We developed a test, based on the detection of 34 microRNAs (miRNAs) from serum, that could identify patients with early stage non-small cell lung carcinomas (NSCLCs) in a population of asymptomatic high-risk individuals with 80% accuracy. The signature could assign disease probability accurately either in asymptomatic or symptomatic patients, is able to distinguish between benign and malignant lesions, and to capture the onset of the malignant disease in individual patients over time. Thus, our test displays a number of features of clinical relevance that project its utility in programs for the early detection of NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
A microRNA polycistron as a potential human oncogene
He, L., Thomson, J. M., Hemann, M. T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S. W., Hannon, G. J., et al. (2005) · Nature · doi:10.1038/nature03552 · Cited by 3,483
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023
c-Myc-regulated microRNAs modulate E2F1 expression
O'Donnell, K. A., Wentzel, E. A., Zeller, K. I., Dang, C. V., & Mendell, J. T. (2005) · Nature · doi:10.1038/nature03677 · Cited by 2,347
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Survival of Patients with Stage I Lung Cancer Detected on CT Screening
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060476 · Cited by 1,706
Ventura, A., Young, A. G., Winslow, M. M., Lintault, L., Meissner, A., Erkeland, S. J., Newman, J., Bronson, R. T., Crowley, D., Stone, J. R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.019 · Cited by 1,590
The National Lung Screening Trial: Overview and Study Design
National Lung Screening Trial Research Team (2011) · Radiology · doi:10.1148/radiol.10091808 · Cited by 1,274
Kroh, E. M., Parkin, R. K., Mitchell, P. S., & Tewari, M. (2010) · Methods · doi:10.1016/j.ymeth.2010.01.032 · Cited by 1,175
Circulating microRNAs, potential biomarkers for drug-induced liver injury
Wang, K., Zhang, S., Marzolf, B., Troisch, P., Brightman, A., Hu, Z., Hood, L. E., & Galas, D. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813371106 · Cited by 1,149
miRiad Roles for the miR-17-92 Cluster in Development and Disease
Mendell, J. T. (2008) · Cell · doi:10.1016/j.cell.2008.04.001 · Cited by 1,089
Jemal, A., Thun, M. J., Ries, L. A. G., Howe, H. L., Weir, H. K., Center, M. M., Ward, E., Wu, X.-C., Eheman, C., Anderson, R., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn389 · Cited by 957
Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.9342 · Cited by 798
Boeri, M., Verri, C., Conte, D., Roz, L., Modena, P., Facchinetti, F., Calabrò, E., Croce, C. M., Pastorino, U., & Sozzi, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100048108 · Cited by 722
Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
McDonald, J. S., Milosevic, D., Reddi, H. V., Grebe, S. K., & Algeciras-Schimnich, A. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.157198 · Cited by 679
Lung Cancer Screening with CT: Mayo Clinic Experience
Swensen, S. J., Jett, J. R., Hartman, T. E., Midthun, D. E., Sloan, J. A., Sykes, A.-M., Aughenbaugh, G. L., & Clemens, M. A. (2003) · Radiology · doi:10.1148/radiol.2263020036 · Cited by 665
Mortality from smoking worldwide
Peto, R., Lopez, A. D., Boreham, J., Thun, M., Heath, C., & Doll, R. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011519 · Cited by 638
Plasma MicroRNAs as Sensitive and Specific Biomarkers of Tissue Injury
Laterza, O. F., Lim, L., Garrett-Engele, P. W., Vlasakova, K., Muniappa, N., Tanaka, W. K., Johnson, J. M., Sina, J. F., Fare, T. L., Sistare, F. D., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.131797 · Cited by 619
Computed Tomography Screening and Lung Cancer Outcomes
Bach, P. B. (2007) · JAMA · doi:10.1001/jama.297.9.953 · Cited by 567
Regression of murine lung tumors by the let-7 microRNA
Trang, P., Medina, P. P., Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Homer, R., Brown, D., Bader, A. G., Weidhaas, J. B., et al. (2010) · Oncogene · doi:10.1038/onc.2009.445 · Cited by 500
Pastorino, U., Bellomi, M., Landoni, C., De Fiori, E., Arnaldi, P., Picchio, M., Pelosi, G., Boyle, P., & Fazio, F. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14188-8 · Cited by 452
Self-citationPlasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases
Zhang, Y., Jia, Y., Zheng, R., Guo, Y., Wang, Y., Guo, H., Fei, M., & Sun, S. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147850 · Cited by 415
Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
Shen, J., Todd, N. W., Zhang, H., Yu, L., Lingxiao, X., Mei, Y., Guarnera, M., Liao, J., Chou, A., Lu, C. L., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2010.194 · Cited by 383
Liu, B., Peng, X.-C., Zheng, X.-L., Wang, J., & Qin, Y.-W. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.01.010 · Cited by 326
Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients
Tanaka, M., Oikawa, K., Takanashi, M., Kudo, M., Ohyashiki, J., Ohyashiki, K., & Kuroda, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005532 · Cited by 298
Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer
Heegaard, N. H. H., Schetter, A. J., Welsh, J. A., Yoneda, M., Bowman, E. D., & Harris, C. C. (2012) · International Journal of Cancer · doi:10.1002/ijc.26153 · Cited by 288
Human Traumatic Brain Injury Alters Plasma microRNA Levels
Redell, J. B., Moore, A. N., Ward, N. H., Hergenroeder, G. W., & Dash, P. K. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1481 · Cited by 282
miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer
Foss, K. M., Sima, C., Ugolini, D., Neri, M., Allen, K. E., & Weiss, G. J. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318208c785 · Cited by 281
Serum microRNAs as powerful cancer biomarkers
Wittmann, J., & Jäck, H.-M. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.07.002 · Cited by 257
MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines
Crawford, M., Brawner, E., Batte, K., Yu, L., Hunter, M. G., Otterson, G. A., Nuovo, G., Marsh, C. B., & Nana-Sinkam, S. P. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.090 · Cited by 256
MicroRNA-134 plasma levels before and after treatment for bipolar mania
Rong, H., Liu, T. B., Yang, K. J., Yang, H. C., Wu, D. H., Liao, C. P., Hong, F., Yang, H. Z., Wan, F., Ye, X. Y., et al. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.04.028 · Cited by 189
Veronesi, G., Bellomi, M., Mulshine, J. L., Pelosi, G., Scanagatta, P., Paganelli, G., Maisonneuve, P., Preda, L., Leo, F., Bertolotti, R., et al. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.01.001 · Cited by 176
Self-citationEstimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study
McMahon, P. M., Kong, C. Y., Johnson, B. E., Weinstein, M. C., Weeks, J. C., Kuntz, K. M., Shepard, J.-A. O., Swensen, S. J., & Gazelle, G. S. (2008) · Radiology · doi:10.1148/radiol.2481071446 · Cited by 102
Reich, J. M. (2008) · Thorax · doi:10.1136/thx.2007.079673 · Cited by 82
MicroRNA expression profile of bronchioalveolar stem cells from mouse lung
Qian, S., Ding, J., Xie, R., An, J., Xu-jun, A., Zhao, Z.-G., Sun, J., Duan, Y., Chen, Z., & Zhu, B. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.052 · Cited by 76
Overstating the Evidence for Lung Cancer Screening
Welch, H. G., Woloshin, S., Schwartz, L. M., Gordis, L., Gøtzsche, P. C., Harris, R., Kramer, B. S., & Ransohoff, D. F. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.21.2289 · Cited by 75
Chien, C., & Chen, T. H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23413 · Cited by 56
microRNA expression in erythropoiesis and erythroid disorders
Lawrie, C. H. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07978.x · Cited by 54
Cited by
Global Epidemiology of Lung Cancer
Barta, J. A., Powell, C. A., & Wisnivesky, J. P. (2019) · Annals of Global Health · doi:10.5334/aogh.2419 · Cited by 1,575
MicroRNA: Function, Detection, and Bioanalysis
Dong, H., Lei, J., Ding, L., Wen, Y., Ju, H., & Zhang, X. (2013) · Chemical Reviews · doi:10.1021/cr300362f · Cited by 1,224
MicroRNA-Based Diagnosis and Therapy
Ho, P. T. B., Clark, I. M., & Le, L. T. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137167 · Cited by 630
Reddy, K. B. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0185-1 · Cited by 613
Jin, X., Chen, Y., Chen, H., Fei, S., Chen, D., Cai, X., Liu, L., Lin, B., Su, H., Zhao, L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0577 · Cited by 558
Metadata
- Authors
- Bianchi, F., Nicassio, F., Marzi, M., Belloni, E., Dall'Olio, V., Bernard, L., Pelosi, G., Maisonneuve, P., Veronesi, G., & Di Fiore, P. P.
- Venue
- EMBO Molecular Medicine
- Published
- 2011-07-11
- Volume
- 3
- Issue
- 8
- Pages
- 495-503
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2122080063
- Cited by
- 351
- References
- 45
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.